Incremental Value of Arterial Stiffness Over Traditional Risk Factors in Predicting Subclinical Cardiovascular Remodeling in Patients With Moderate Chronic Renal Failure
Restricted accessResearch articleFirst published online November, 2011
Incremental Value of Arterial Stiffness Over Traditional Risk Factors in Predicting Subclinical Cardiovascular Remodeling in Patients With Moderate Chronic Renal Failure
Cardiovascular remodeling in chronic kidney disease (CKD) is responsible for the high mortality found in this condition. A total of 89 consecutive outpatients with stage III CKD and 52 patients with stage II CKD with similar degree of traditional atherosclerotic risk factors underwent routine echocardiographic and carotid Doppler examination, evaluating vascular and cardiac remodeling (intima—media thickness [IMT] and left ventricular mass index [LVMi]), and its relation with arterial stiffness, determined in the same examination, using an echo-tracking technique. Also the absolute values of LVMi and IMT were statistically similar between the 2 groups, their determinants were completely different, only in stage III the markers of renal impairment and arterial stiffness being independent predictors of cardiac and vascular modifications. We concluded that macroanatomical measurements do not fully describe cardiovascular remodeling in this setting. Arterial stiffness echo-tracking derived could add valuable information, being an easy-to-perform parameter during a routine examination.
RakhitDJZhangXHLeanoRArmstrongKAIsbelNMMarwickTH. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am Heart J. 2007;153(4):656–664.
2.
BlacherJGuerinAPPannierBMarchaisSJSafarMELondonGM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–2439.
3.
GuerinAPBlacherJPannierBMarchaisSJSafarMELondonGM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103(7):987–992.
4.
GoldwasserPMittmanNAntignaniA. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993;3(9):1613–1622.
5.
MarkPBJohnstonNGroenningBA. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69(10):1839–1845.
6.
OgawaTShimadaMIshidaH. Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis. Int Urol Nephrol. 2009;41(3):739–745.
7.
KawadaHSumimotoTOkayamaHHiwadaK. Structure and function of the left ventricle and carotid artery in hemodialysis patients. Hypertens Res. 2001;24(3):221–227.
8.
ShojiaTMaekawabKEmotoaM. Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis. 2010;210(1):145–149.
9.
Antonini-CanterinFCarerjSDi BelloV. Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist’s point of view. Eur J Echocardiogr. 2009;10(1):36–43.
10.
PignoliPTremoliEPoliAOrestePPaolettiR. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–1406.
11.
SchillerNBShahPMCrawfordM. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–367.
12.
DevereuxRBAlonsoDRLutasEM. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458.
13.
CockcroftDWGaultMH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
14.
HutchisonAWrightJ. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag. 2009;5:713–722.
15.
FoleyRNMurrayAMLiS. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–495.
16.
GoASChertowGMFanDMcCullochCEHsuCY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
17.
ZoungasSCameronJDKerrPG. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis. 2007;50(4):622–630.
18.
BaigentCLandrayM. Which cardiovascular risk factors matter in chronic kidney disease?. Nephrol Dial Transplant. 2007;22(1):9–11.
19.
CeceljaMChowienczykP. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension. a systematic review. Hypertension. 2009;54(6):1328–1336.
20.
ChueCCTownendNJSteedsRPFerroCJ. Arterial stiffness in chronic kidney disease: causes and consequences. Heart. 2010;96(11):817–823.
21.
RigattoCLevinAHouseAABarrettBCarlisleEFineA. Atheroma progression in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):291–298.
22.
SarnakMJLeveyASSchoolwerthAC. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–2169.
23.
WannerCKraneVMärzW. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238–248.
24.
HoldaasHFellstromBJardineAG. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet. 2003;361(9374):2024–2231.
25.
LindnerACharraBSherrardDJScribnerBH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290(13):697–701.
26.
EdwardsNCFerroCJTownendJNSteedsRP. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart. 2008;94(8):1038–1043.
27.
EdwardsNCHirthAFerroCJTownendJNSteedsRP. Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?. J Am Soc Echocardiogr. 2008;21(12):1293–1298.
28.
Di BelloVCarerjSPerticoneF. Carotid intima-media thickness in asymptomatic patients with arterial hypertension without clinical cardiovascular disease; relation with left ventricle geometry and mass and coexisting risk factors. Angiology. 2010;60(6):705–713.
